These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 18646606

  • 1. [Characteristics of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease].
    Kawa K.
    Rinsho Ketsueki; 2008 Jun; 49(6):390-6. PubMed ID: 18646606
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Blood stem-cell transplantation for chronic active Epstein-Barr virus with lymphoproliferation.
    Okamura T, Hatsukawa Y, Arai H, Inoue M, Kawa K.
    Lancet; 2000 Jul 15; 356(9225):223-4. PubMed ID: 10963205
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD.
    Ohshima K, Kimura H, Yoshino T, Kim CW, Ko YH, Lee SS, Peh SC, Chan JK, CAEBV Study Group.
    Pathol Int; 2008 Apr 15; 58(4):209-17. PubMed ID: 18324913
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Impact of melphalan dose during reduced-intensity conditioning on engraftment of cord blood transplantation for chronic Epstein-Barr virus-associated T or NK cell lymphoproliferative diseases.
    Mayumi A, Sawada A, Sato M, Shimizu M, Ioi A, Higuchi K, Yasui M, Kawa K, Inoue M.
    Pediatr Blood Cancer; 2020 Sep 15; 67(9):e28536. PubMed ID: 32564520
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Epstein-Barr virus-associated lymphoproliferative disorders.
    Rezk SA, Weiss LM.
    Hum Pathol; 2007 Sep 15; 38(9):1293-304. PubMed ID: 17707260
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Diagnosis and treatment for EBV-associated lymphoproliferative disease].
    Kawa K.
    Nihon Rinsho; 2006 Mar 15; 64 Suppl 3():682-6. PubMed ID: 16615559
    [No Abstract] [Full Text] [Related]

  • 16. Umbilical cord blood as an alternative source of reduced-intensity hematopoietic stem cell transplantation for chronic Epstein-Barr virus-associated T or natural killer cell lymphoproliferative diseases.
    Sawada A, Inoue M, Koyama-Sato M, Kondo O, Yamada K, Shimizu M, Isaka K, Kimoto T, Kikuchi H, Tokimasa S, Yasui M, Kawa K.
    Biol Blood Marrow Transplant; 2014 Feb 15; 20(2):214-21. PubMed ID: 24188918
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorders.
    Cai Q, Chen K, Young KH.
    Exp Mol Med; 2015 Jan 23; 47(1):e133. PubMed ID: 25613730
    [Abstract] [Full Text] [Related]

  • 19. Epstein-Barr virus-associated B cell lymphoproliferative disease after non-myeloablative allogeneic stem cell transplantation.
    Milpied N, Coste-Burel M, Accard F, Moreau A, Moreau P, Garand R, Harousseau JL.
    Bone Marrow Transplant; 1999 Mar 23; 23(6):629-30. PubMed ID: 10217196
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.